Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Efficacy of Inhaled Insulin (AIR) vs Injected Insulin in Diabetes with Asthma or COPD
NCT00157339Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- Aug 2005
- Primary completion
- May 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 16
01
Overview
A Phase 3 trial of AIR Inhaled Insulin in type 1 diabetes mellitus (T1D), type 2 diabetes mellitus (T2DM), sponsored by Eli Lilly and Company. Started Aug 2005; status: completed.
02
Drugs
AIR Inhaled Insulin
03
Conditions
type 1 diabetes mellitus (T1D)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00157339.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00157339.